135 related articles for article (PubMed ID: 37220659)
1. The Outcome of Patients with Pulmonary Arterial Hypertension and Chronic Thromboembolic Pulmonary Hypertension during the COVID-19 Pandemic.
Serati A; Keshmiri MS; Shafaghi S; Mohammad MM; Kashani BS; Naghashzadeh F; Mohamadifar A; Shafaghi M; Noorali S; Hajimoradi M; Astani B; Aghdasi S; Riahi M; Alavi S; Malek R; Movahed MR
Crit Pathw Cardiol; 2023 Jun; 22(2):60-64. PubMed ID: 37220659
[TBL] [Abstract][Full Text] [Related]
2. Outcomes of COVID-19 in patients vaccinated and unvaccinated against SARS-CoV-2 and suffering from pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension.
Wieteska-Miłek M; Kuśmierczyk-Droszcz B; Ryczek R; Szmit S; Florczyk M; Mańczak R; Betkier-Lipińska K; Hoffman P; Krzesiński P; Torbicki A; Kurzyna M
Pol Arch Intern Med; 2023 May; 133(5):. PubMed ID: 36602859
[TBL] [Abstract][Full Text] [Related]
3. Clinical observations of COVID-19 infection in patients with chronic thromboembolic pulmonary hypertension.
Kamenskaya OV; Loginova IY; Klinkova AS; Lomivorotov VV; Chernyavsky AM
Kardiologiia; 2021 Jul; 61(6):28-34. PubMed ID: 34311685
[TBL] [Abstract][Full Text] [Related]
4. COVID-19 patients may become predisposed to pulmonary arterial hypertension.
Suzuki YJ; Nikolaienko SI; Shults NV; Gychka SG
Med Hypotheses; 2021 Feb; 147():110483. PubMed ID: 33444904
[TBL] [Abstract][Full Text] [Related]
5. Management of COVID-19 in Patients with Pulmonary Arterial Hypertension.
Farmakis IT; Giannakoulas G
Heart Fail Clin; 2023 Jan; 19(1):107-114. PubMed ID: 36435565
[TBL] [Abstract][Full Text] [Related]
6. COVID-19 in Patients with Pulmonary Hypertension: A National Prospective Cohort Study.
Montani D; Certain MC; Weatherald J; Jaïs X; Bulifon S; Noel-Savina E; Nieves A; Renard S; Traclet J; Bouvaist H; Riou M; de Groote P; Moceri P; Bertoletti L; Favrolt N; Guillaumot A; Jutant EM; Beurnier A; Boucly A; Ebstein N; Jevnikar M; Pichon J; Keddache S; Preda M; Roche A; Solinas S; Seferian A; Reynaud-Gaubert M; Cottin V; Savale L; Humbert M; Sitbon O;
Am J Respir Crit Care Med; 2022 Sep; 206(5):573-583. PubMed ID: 35549842
[No Abstract] [Full Text] [Related]
7. A Survey-based Estimate of COVID-19 Incidence and Outcomes among Patients with Pulmonary Arterial Hypertension or Chronic Thromboembolic Pulmonary Hypertension and Impact on the Process of Care.
Lee JD; Burger CD; Delossantos GB; Grinnan D; Ralph DD; Rayner SG; Ryan JJ; Safdar Z; Ventetuolo CE; Zamanian RT; Leary PJ
Ann Am Thorac Soc; 2020 Dec; 17(12):1576-1582. PubMed ID: 32726561
[No Abstract] [Full Text] [Related]
8. Long COVID syndrome after SARS-CoV-2 survival in patients with pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension.
Wieteska-Miłek M; Kuśmierczyk-Droszcz B; Betkier-Lipińska K; Szmit S; Florczyk M; Zieliński P; Hoffman P; Krzesińki P; Kurzyna M
Pulm Circ; 2023 Apr; 13(2):e12244. PubMed ID: 37266140
[TBL] [Abstract][Full Text] [Related]
9. Impact of the COVID-19 Pandemic on Pulmonary Hypertension Patients: Insights from the BNP-PL National Database.
Mamzer A; Waligora M; Kopec G; Ptaszynska-Kopczynska K; Kurzyna M; Darocha S; Florczyk M; Mroczek E; Mularek-Kubzdela T; Smukowska-Gorynia A; Wrotynski M; Chrzanowski L; Dzikowska-Diduch O; Perzanowska-Brzeszkiewicz K; Pruszczyk P; Skoczylas I; Lewicka E; Blaszczak P; Karasek D; Kusmierczyk-Droszcz B; Mizia-Stec K; Kaminski K; Jachec W; Peregud-Pogorzelska M; Doboszynska A; Gasior Z; Tomaszewski M; Pawlak A; Zablocka W; Ryczek R; Widejko-Pietkiewicz K; Kasprzak JD
Int J Environ Res Public Health; 2022 Jul; 19(14):. PubMed ID: 35886278
[TBL] [Abstract][Full Text] [Related]
10. Interaction of Biochemical Processes between Chronic Obstructive Pulmonary Disease (COPD), Pulmonary Arterial Hypertension (PAH), and Coronavirus Disease 2019 (COVID-19).
Tian Z; Cen L
Pol J Microbiol; 2023 Jun; 72(2):143-154. PubMed ID: 37216361
[TBL] [Abstract][Full Text] [Related]
11. COVID-19 Vaccination in Patients with Pulmonary Arterial Hypertension and Chronic Thromboembolic Pulmonary Hypertension: Safety Profile and Reasons for Opting against Vaccination.
Wieteska-Miłek M; Szmit S; Florczyk M; Kuśmierczyk-Droszcz B; Ryczek R; Kurzyna M
Vaccines (Basel); 2021 Nov; 9(12):. PubMed ID: 34960141
[TBL] [Abstract][Full Text] [Related]
12. Risk assessment in patients with pulmonary arterial hypertension in the era of COVID 19 pandemic and the telehealth revolution: State of the art review.
Wesley Milks M; Sahay S; Benza RL; Farber HW
J Heart Lung Transplant; 2021 Mar; 40(3):172-182. PubMed ID: 33414063
[TBL] [Abstract][Full Text] [Related]
13. Efficacy of Sildenafil in Patients with Severe COVID-19 and Pulmonary Arterial Hypertension.
Oliynyk OV; Rorat M; Strepetova OV; Dubrov SO; Guryanov VG; Oliynyk YV; Kulivets OS; Ślifirczyk A; Barg W
Viruses; 2023 May; 15(5):. PubMed ID: 37243243
[TBL] [Abstract][Full Text] [Related]
14. The paradox of pulmonary arterial hypertension in Italy in the COVID-19 era: is risk of disease progression around the corner?
Badagliacca R; Papa S; D'Alto M; Ghio S; Agostoni P; Ameri P; Argiento P; Brunetti ND; Casamassima V; Casu G; Cedrone N; Confalonieri M; Corda M; Correale M; D'Agostino C; De Michele L; Famoso G; Galgano G; Greco A; Lombardi CM; Manzi G; Madonna R; Mercurio V; Mulè M; Paciocco G; Romaniello A; Romeo E; Scelsi L; Serra W; Stolfo D; Toma M; Vatrano M; Vitulo P; Vizza CD;
Eur Respir J; 2022 Oct; 60(4):. PubMed ID: 35301247
[TBL] [Abstract][Full Text] [Related]
15. Pulmonary arterial hypertension and COVID-19: Piecing the puzzle.
Charif F; Dakroub F; Bou Akl I; Kularatne M; Montani D
Respir Med Res; 2023 Nov; 84():101053. PubMed ID: 38236767
[TBL] [Abstract][Full Text] [Related]
16. Epidemiological and clinical characteristics of coronavirus disease (COVID-19) cases at a screening clinic during the early outbreak period: a single-centre study.
Khan M; Khan H; Khan S; Nawaz M
J Med Microbiol; 2020 Aug; 69(8):1114-1123. PubMed ID: 32783802
[No Abstract] [Full Text] [Related]
17. Physical Activity in Pulmonary Arterial Hypertension during Pandemic COVID-19 and the Potential Impact of Mental Factors.
Wieteska-Miłek M; Szmit S; Florczyk M; Witowicz A; Kurzyna M
Int J Environ Res Public Health; 2022 Jul; 19(14):. PubMed ID: 35886194
[TBL] [Abstract][Full Text] [Related]
18. Pulmonary hypertension and right ventricular involvement in hospitalised patients with COVID-19.
Pagnesi M; Baldetti L; Beneduce A; Calvo F; Gramegna M; Pazzanese V; Ingallina G; Napolano A; Finazzi R; Ruggeri A; Ajello S; Melisurgo G; Camici PG; Scarpellini P; Tresoldi M; Landoni G; Ciceri F; Scandroglio AM; Agricola E; Cappelletti AM
Heart; 2020 Sep; 106(17):1324-1331. PubMed ID: 32675217
[TBL] [Abstract][Full Text] [Related]
19. Racial Disparities in the Risk for Thromboembolic Events in COVID-19 Patients during the Height of the SARS-CoV-2 Pandemic and Impact on Outcomes.
Nam J; D'Andrea M; O'Hara A; Staszewski L; Pozin J; Wozniak A; Korepta L; Halandras P; Soult M; Aulivola B
Ann Vasc Surg; 2022 Nov; 87():278-285. PubMed ID: 35589032
[TBL] [Abstract][Full Text] [Related]
20. Clinical-Epidemiological Characteristics of the First Patients Diagnosed with COVID-19 in Cuba.
Molina-Águila N; Cruz-Rodríguez E; Ferrán-Torres RM; Galindo-Santana BM; López-Almaguer Y; Romero-Placeres M
MEDICC Rev; 2021 Apr; 23(2):15. PubMed ID: 33974611
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
